54
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Analysis of immune status after iodine-125 permanent brachytherapy in prostate cancer

, , , , , , , & show all
Pages 2561-2567 | Published online: 15 May 2017

References

  • SiegelRMaJZouZJemalACancer statistics, 2014CA Cancer J Clin201464192924399786
  • CuzickJThoratMAAndrioleGPrevention and early detection of prostate cancerLancet Oncol20141511E484E49225281467
  • NesslingerNJSahotaRAStoneBStandard treatments induce antigen-specific immune responses in prostate cancerClin Cancer Res20071351493150217332294
  • MorseMDMcNeelDGProstate cancer patients on androgen deprivation therapy develop persistent changes in adaptive immune responsesHum Immunol201071549650420153396
  • FriedmanEJImmune modulation by ionizing radiation and its implications for cancer immunotherapyCurr Pharm Des20028191765178012171547
  • McBrideWHChiangCSOlsonJLA sense of danger from radiationRadiat Res2004162111915222781
  • BoseAChakrabortyTChakrabortyKPalSBaralRDysregulation in immune functions is reflected in tumor cell cytotoxicity by peripheral blood mononuclear cells from head and neck squamous cell carcinoma patientsCancer Immun200881018547033
  • GalonJCostesASanchez-CaboFType, density, and location of immune cells within human colorectal tumors predict clinical outcomeScience200631357951960196417008531
  • AzimiFScolyerRARumchevaPTumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanomaJ Clin Oncol201230212678268322711850
  • LiuRLuoFZhangZXuYIodine-125 seed implantation and deferred transurethral resection of the prostate for patients with lower urinary tract symptoms and localized prostate cancerClin Genitourin Cancer201311325125523375828
  • O’SullivanTSaddawi-KonefkaRVermiWCancer immunoediting by the innate immune system in the absence of adaptive immunityJ Exp Med2012209101869188222927549
  • ShankaranVIkedaHBruceATIFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicityNature200141068321107111111323675
  • Di CarloED’AntuonoTPompaPThe lack of epithelial interleukin-7 and BAFF/BLyS gene expression in prostate cancer as a possible mechanism of tumor escape from immunosurveillanceClin Cancer Res20091592979298719366834
  • SiTGWangJPGuoZAnalysis of circulating regulatory T cells (CD4+CD25+CD127-) after cryosurgery in prostate cancerAsian J Androl201315446146523728588
  • BrunoGSaracinoAMonnoLAngaranoGThe revival of an “old” marker: CD4/CD8 ratioAIDS Rev Epub201729
  • ShibuyaTYKimSNguyenKCovalent linking of proteins and cytokines to suture: enhancing the immune response of head and neck cancer patientsLaryngoscope2003113111870188414603040
  • FloerckenATakvorianASinghAModulation of regulatory T cells and myeloid-derived suppressor cells by sorafenib and sunitinib in renal cell carcinoma patientsJ Clin Oncol20092715
  • Degl’InnocentiEGrioniMCapuanoGPeripheral T-cell tolerance associated with prostate cancer is independent from CD4(+) CD25(+) regulatory T cellsCancer Res200868129230018172322
  • SorrentinoCMusianiPPompaPCipolloneGDi CarloEAndrogen deprivation boosts prostatic infiltration of cytotoxic and regulatory T lymphocytes and has no effect on disease-free survival in prostate cancer patientsClin Cancer Res20111761571158121159885
  • BronteVKasicTGriGBoosting antitumor responses of T lymphocytes infiltrating human prostate cancersJ Exp Med200520181257126815824085
  • KarjaVAaltomaaSLipponenPIsotaloTTaljaMMokkaRTumour-infiltrating lymphocytes: A prognostic factor of PSA-free survival in patients with local prostate carcinoma treated by radical prostatectomyAnticancer Res2005256C4435443816334122